Le Lézard
Classified in: Health
Subjects: AWD, VET

GlobalMed CEO Joel Barthelemy Named Global Business Executive of the Year by Global Chamber Phoenix


SCOTTSDALE, Ariz., Oct. 3, 2017 /PRNewswire/ -- GlobalMed, an international provider of telehealth solutions, announced today that CEO Joel Barthelemy has been recognized as Global Business Executive of the Year by the Phoenix chapter of Global Chamber, the first chamber of commerce to focus on growing cross-border trade and investment in a collaborative way across 525 metro areas around the world.

To download a photo of Barthelemy receiving the award, click this:

https://www.flickr.com/photos/36981810@N07/23613459628/in/dateposted-public/

GlobalMed's evidence-based telehealth solutions power the largest telehealth programs in the world, enhancing diagnostics and improving patient outcomes in 55 countries and for more than 3.5 million consults each year. GlobalMed is the only vertically integrated provider of products and technology that deliver HIPAA-compliant video collaboration among healthcare professionals and patients, regardless of location. Visit GlobalMed.com. (PRNewsfoto/GlobalMed)

Barthelemy was recognized for building the global profile of metropolitan Phoenix, the nation's fifth largest city, by "sweeping the world with telemedicine, right from Arizona."  GlobalMed's technology is currently used in 55 countries.

Global Chamber's mission is to accelerate cross-border trade and investment by engaging top executives and regional leaders to grow business, increase community success and change the world.

"There's a good reason why the word global has been in our company name since we launched in 2002," explained Barthelemy. "Telehealth makes it easy to export and replicate the universal tenets of healthcare to distant cultures that are far different from our own. Core concepts like patient access to quality care, accurate diagnostics and cost management are important to every demographic around the world. I am honored to be recognized for leading a global telehealth company based in Phoenix."

The award ceremony was held on Oct. 2 at the PHX 2017 Grow Globally Fair. The "Grow Globally Fair" is an annual trade fair event for exporters, importers and investors doing international business.

About GlobalMed®

GlobalMed's evidence-based telehealth solutions power the largest telehealth programs in the world, facilitating 3.5 million consults each year, enhancing diagnostics and improving patient outcomes in 55 countries. GlobalMed is the only vertically integrated provider of products and technology that deliver HIPAA-compliant video collaboration among healthcare professionals and patients, regardless of location. GlobalMed partners with leading medical groups, healthcare enterprises and government, and is the telehealth provider for the White House.

Founded in 2002 by a Marine Corps Reserve Veteran still serving as CEO, GlobalMed is proud to be a Veteran Owned Small Business (VOSB).

Media contact: Marcia Rhodes, Amendola Communications, (480) 664-8412, ext. 15 / [email protected]

 

SOURCE GlobalMed


These press releases may also interest you

at 01:10
HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that HAYA's Co-Founders Samir Ounzain and Daniel Blessing have received the inaugural Andreas & Thomas...

at 01:05
The committee of the newly established Andreas & Thomas Struengmann Award today announced that Samir Ounzain and Daniel Blessing, the two co-founders of HAYA Therapeutics, are the inaugural winners of the Andreas & Thomas Struengmann Award....

at 01:05
ReCerise Therapeutics Inc. (CEO Yong-Bae Kim), has announced its selection for a grant from the Ministry of Trade, Industry and Energy (MOTIE) of South Korea. The grant aims to support the development of tailored targeted therapies for refractory...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Pyzchiva® (ustekinumab-ttwe) is approved by FDA for all indications of reference...

at 01:00
Education Cannot Wait (ECW) and the Aga Khan Foundation (AKF) announce an expanded three-year partnership that will improve holistic quality learning outcomes and quality learning environments for crisis-affected learners in Afghanistan, Pakistan and...

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...



News published on and distributed by: